✦ LIBER ✦

Non-HIV lentiviral vectors

Book ID: 101300252
Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 52 KB
Volume: 1
Category: Article
ISSN: 1099-498X
DOI: 10.1002/(sici)1521-2254(199911/12)1:6<441::aid-jgm67>3.0.co;2-3

No coin nor oath required. For personal study only.

✦ Synopsis

In 1995 Professor Kingsman co-founded Oxford BioMedica to develop and commercialise gene technologies arising out of research undertaken by the Group at the University. The company uses advanced gene delivery technologies for the treatment of disease in the areas of oncology, viral infection, neurobiology and genetic de®ciency. In December 1996 Oxford BioMedica was ¯oated on the UK Alternative

📜 SIMILAR VOLUMES

Lentiviral vectors for HIV disease preve

Lentiviral vectors for HIV disease prevention and treatment

✍ Franck Lemiale; Nikolay Korokhov 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 294 KB

Lentiviral vectors

✍ P. V. Spirin; A. E. Vilgelm; V. S. Prassolov 📂 Article 📅 2008 🏛 SP MAIK Nauka/Interperiodica 🌐 English ⚖ 322 KB

Lentiviral Vectors

✍ Verma, Inder 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 72 KB

Chimeric HIV-1 and HIV-2 lentiviral vect

Chimeric HIV-1 and HIV-2 lentiviral vectors with added safety insurance

✍ Geetanjali Sachdeva; Jenice D'Costa; Jang E. Cho; Kritika Kachapati; Vidita Chou 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

## Abstract Lentiviruses are unique in their ability to infect both dividing and non‐dividing cells. This makes the vectors derived from them particularly useful for gene transfer into non‐dividing cells, including stem cells. Lentiviral vectors are becoming the vectors of choice for si/shRNA deliv

An HIV-based lentiviral vector as HIV va

An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization

✍ Franck Lemiale; Benyam Asefa; Delia Ye; Christopher Chen; Nikolay Korokhov; Laur 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 999 KB

Lentiviral vectors that carry anti-HIV s

Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions

✍ Olivier ter Brake; Ben Berkhout 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB

## Abstract ## Background HIV‐1 replication can be inhibited with RNA interference (RNAi) by expression of short hairpin RNA (shRNA) from a lentiviral vector. Because lentiviral vectors are based on HIV‐1, viral sequences in the vector system are potential targets for the antiviral shRNAs. Here, w